Healthtech firm Indegene raised $200 mn from Carlyle Group, Brighton Park
Healthtech firm Indegene has raised $200 mn from US-based investment firms Carlyle Group and Brighton Park. According to sources, the two investment companies have picked up minority stakes in Indegene.
Indegene claims to be working with 75 of the world’s largest pharma companies. It crunches numbers to prepare legally compliant clinical data, which helps pharma companies communicate comprehensive details of a specific drug to medical representatives and doctors.